Published in Pain and Central Nervous System Week, February 20th, 2012
"They benefited from an initial assessment that included a neuropsychological evaluation and ERP. We followed them up for 1 ear, and during their last visit, they benefited again from ERP and neuro-sychological tests. At the end of the study, 2 subgroups of patients with MCI were differentiated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.